STEMCELL Technologies Delivers a New Method for Identifying and Quantifying Neural Stem and Progenitor Cells In Vitro
The NeuroCult® Neural Colony-Forming Cell Assay increases accuracy of studying neural stem cells in vitro and therefore, the evaluation of the therapeutic potential of neural stem cells. Vancouver, BC (PRWEB) March 28, 2008 -- STEMCELL Technologies, a leader in specialized cell culture media, cell separation products and ancillary reagents for stem cell research, today announced a landmark publication that improves the identification and quantification of neural stem and progenitor cells. "The NeuroCult® Neural Colony-Forming Cell Assay is an improvement over the widely used Neurosphere Assay because it provides researchers with a reliable way to detect alterations in neural stem cell frequency, which is necessary for evaluating the cells' therapeutic potential," states Dr. Sharon A. Louis, Senior Scientist at STEMCELL Technologies. "Our findings imply that while the Neurosphere Assay provides a simple means to isolate and expand neural stem cells harvested from the embryonic and adult mammalian CNS, its application as a quantitative in vitro assay for measuring NSC frequency is limited. Presently, the Neurosphere Assay is the most frequently adopted method for isolating, expanding and calculating the frequency of neural stem cells, so our findings will impact highly cited research performed using this method." The new NeuroCult® Neural Colony-Forming Cell Assay is a significant advancement in the neural stem cell field because it discriminates between neural stem cells and neural progenitor cells based on the size of the colonies they form (proliferative potential), allowing researchers to easily and accurately distinguish and quantify these cell populations in vitro. The results of this study are published in the article "Enumeration of Neural Stem and Progenitor Cells in the Neural Colony-Forming Cell Assay" in the April, 2008 issue of Stem Cells. Click here to access the full paper through open access. The NeuroCult® Neural Colony-Forming Cell Assay was developed by Dr. Sharon Louis and Dr. Brent A. Reynolds at STEMCELL Technologies with further work performed in collaboration with Dr. Brent A. Reynolds and researchers at the Queensland Brain Institute, University of Queensland, Australia. Partial support was also provided from the National Health and Medical Research Council of Australia project grant and a Pfizer Australia Senior Research Fellowship to Rietze R. L. For basic information about neural stem and progenitor cells, visit http://www.stemcell.com/news_info/pr_ncfc_mar08.aspx. Contact:
Diane Miller
STEMCELL Technologies
T. 604.877.0713
E. diane.miller@STEMCELL.com About STEMCELL Technologies
STEMCELL Technologies is a privately owned biotechnology company located in Vancouver, British Columbia that provides specialized cell culture media, cell separation products and ancillary reagents for stem cell research. For more information about STEMCELL Technologies visit http://www.stemcell.com. ###
Simillar Articles
 | | StemCell Technologies' Contract Services Launches Re-designed Website |
| Website features new, valuable resources, including educational webcasts, news and events |
|
| | Banyan Biomarkers Announces U.S. Patent for Neural Proteins as Biomarkers for Traumatic Brain Injury |
| Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 “Neural Proteins as Biomarkers for Traumatic Brain Injury,”... |
|
| | S Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China |
| RNL Bio entered into an agreement with Tiantan Puhua Hospital for stem cell treatments for complications including spinal cord injury, hair loss and osteoarthritis. |
|
| | Chenomx, Inc. Partners with Assay Depot to Offer Routine Metabolite Analysis Services for Drug... |
| Chenomx, Inc. (www.chenomx.com) is pleased to announce a partnership with Assay Depot (www.assaydepot.com) to offer routine metabolite analysis services for drug discovery. Chenomx offers a cost... |
|
| | J. Cohan & Associates Celebrating 20 Years Coordinating Immediate Organ Transplants |
| J. Cohan & Associates recently celebrated 20 years of coordinating surgical transplants for clients around the globe. J. Cohan & Associates has been working with hospitals in various countries for... |
|
|
